Basic information Safety Supplier Related

tert-butyl 3,8-diazabicyclo[3.2.1]octane-3-carboxylate

Basic information Safety Supplier Related

tert-butyl 3,8-diazabicyclo[3.2.1]octane-3-carboxylate Basic information

Product Name:
tert-butyl 3,8-diazabicyclo[3.2.1]octane-3-carboxylate
Synonyms:
  • tert-butyl 3,8-diazabicyclo[3.2.1]octane-3-carboxylate
  • 3-Boc-3,8-diazabicyclo[3.2.1]octane
  • 3,8-Diazabicyclo[3.2.1]octane-3-carboxylic acid tert-butyl ester
  • 3-Boc-3,8-diaza-bicyclo[3...
  • tert-butyl 3,8-diazabicyclo[3.2.1]octane-3-carboxylat
  • 3,8-Diazabicyclo[3.2.1]octane-3-carboxylic acid, 1,1-dimethylethyl ester
  • 3,8-Diazabicyclo[3.2.1]octane,N-BOCprotected
  • 8-diazabicyclo[3.2.1]octane-3-carboxylate
CAS:
201162-53-0
MF:
C11H20N2O2
MW:
212.29
Product Categories:
  • CHIRAL CHEMICALS
Mol File:
201162-53-0.mol
More
Less

tert-butyl 3,8-diazabicyclo[3.2.1]octane-3-carboxylate Chemical Properties

Boiling point:
295.4±15.0 °C(Predicted)
Density 
1.076
storage temp. 
2-8°C(protect from light)
pka
9.80±0.20(Predicted)
form 
solid
color 
White
InChI
InChI=1S/C11H20N2O2/c1-11(2,3)15-10(14)13-6-8-4-5-9(7-13)12-8/h8-9,12H,4-7H2,1-3H3
InChIKey
PSDAEKDIOQXLLC-UHFFFAOYSA-N
SMILES
C12NC(CC1)CN(C(OC(C)(C)C)=O)C2
More
Less

Safety Information

HS Code 
2933998090
More
Less

tert-butyl 3,8-diazabicyclo[3.2.1]octane-3-carboxylate Usage And Synthesis

Uses

tert-Butyl 3,8-Diazabicyclo[3.2.1]octane-3-carboxylate is used in preparation of substituted pyrrolo[2,3-b]pyridines for suppressing toxic endoplasmic reticulum stress.

Synthesis

201162-52-9

201162-53-0

The general procedure for the synthesis of tert-butyl 3,8-diazabicyclo[3.2.1]octane-3-carboxylate from tert-butyl 8-benzyl-3,8-diazabicyclo[3.2.1]octane-3-carboxylate was as follows: the product of Example 23A (0.62 g, 0.12 mmol) was dissolved in ethanol (10 mL) and palladium/carbon (Aldrich, 60 mg, 10 wt%) as a catalyst. The reaction was stirred at room temperature for 18 h under an atmosphere of hydrogen (balloon) at 1 atm. Upon completion of the reaction, the reaction mixture was filtered to remove the catalyst and the filtrate was concentrated under reduced pressure to remove the solvent. The resulting crude product was purified by silica gel column chromatography with an eluent ratio of 1% ammonia:9% methanol:90% dichloromethane to afford tert-butyl 3,8-diazabicyclo[3.2.1]octane-3-carboxylate, the target compound (0.44 g, 100% yield). Mass spectral analysis (DC1/NH3) showed m/z 213 (M + H)+.

References

[1] Journal of Medicinal Chemistry, 1998, vol. 41, # 5, p. 674 - 681
[2] Patent: US2005/101602, 2005, A1. Location in patent: Page/Page column 35
[3] Patent: US2005/9841, 2005, A1. Location in patent: Page/Page column 16
[4] Patent: US2005/80095, 2005, A1. Location in patent: Page/Page column 19

tert-butyl 3,8-diazabicyclo[3.2.1]octane-3-carboxylateSupplier

Nanjing Feihao Technology Co., Ltd. Gold
Tel
025-58855213
Email
hongjiling@feihongtec.com
Shanghai Join Biological Pharmaceutical Co., Ltd. Gold
Tel
13818361018
Email
shzuolin@163.com
Jiangsu Aikon Biopharmaceutical R&D co.,Ltd. Gold
Tel
025-66113011 17798518460
Email
cfzhang@aikonchem.com
Anhui Nature Pharmaceutical Co., Ltd. Gold
Tel
19155667820
Email
sales@nuoquanpharm.com
Adamas Reagent, Ltd.
Tel
400-6009262 16621234537
Email
chenyj@titansci.com